Ken Griffin’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $310M | Sell |
2,554,703
-8,401
| -0.3% | -$990K | 0.03% | 394 |
|
|
2026
Q2 | $259M | Buy |
2,563,104
+2,051,217
| +401% | +$212M | 0.03% | 435 |
|
|
2026
Q1 | $49.5M | Buy |
511,887
+394,416
| +336% | +$40.4M | 0.01% | 1369 |
|
|
2025
Q4 | $12.5M | Sell |
117,471
-194,183
| -62% | -$22.5M | ﹤0.01% | 2960 |
|
|
2025
Q3 | $39.6M | Sell |
311,654
-668,742
| -68% | -$79.6M | 0.01% | 1615 |
|
|
2025
Q2 | $120M | Buy |
980,396
+40,341
| +4% | +$4.61M | 0.02% | 650 |
|
|
2025
Q1 | $95.2M | Buy |
940,055
+506,139
| +117% | +$49.4M | 0.02% | 728 |
|
|
2024
Q4 | $40.1M | Sell |
433,916
-341,339
| -44% | -$33.5M | 0.01% | 1474 |
|
|
2024
Q3 | $74.9M | Sell |
775,255
-761,162
| -50% | -$68.4M | 0.01% | 912 |
|
|
2024
Q2 | $132M | Buy |
1,536,417
+672,404
| +78% | +$56.4M | 0.03% | 534 |
|
|
2024
Q1 | $71.4M | Buy |
864,013
+286,230
| +50% | +$21M | 0.01% | 951 |
|
|
2023
Q4 | $38.5M | Sell |
577,783
-1,292,946
| -69% | -$83.7M | 0.01% | 1388 |
|
|
2023
Q3 | $126M | Buy |
1,870,729
+862,748
| +86% | +$59.3M | 0.03% | 511 |
|
|
2023
Q2 | $68.3M | Sell |
1,007,981
-114,111
| -10% | -$7.15M | 0.01% | 825 |
|
|
2023
Q1 | $60.7M | Sell |
1,122,092
-361,328
| -24% | -$21M | 0.01% | 927 |
|
|
2022
Q4 | $88.7M | Buy |
1,483,420
+468,326
| +46% | +$25.5M | 0.02% | 712 |
|
|
2022
Q3 | $45.9M | Buy |
1,015,094
+1,010,217
| +20,714% | +$50.5M | 0.01% | 1140 |
|
|
2022
Q2 | $274K | Sell |
4,877
-68,820
| -93% | -$4.44M | ﹤0.01% | 9994 |
|
|
2022
Q1 | $5.24M | Sell |
73,697
-82,029
| -53% | -$5.38M | ﹤0.01% | 4081 |
|
|
2021
Q4 | $10.2M | Sell |
155,726
-89,080
| -36% | -$5.78M | ﹤0.01% | 3050 |
|
|
2021
Q3 | $18.4M | Sell |
244,806
-940,668
| -79% | -$74.4M | ﹤0.01% | 2127 |
|
|
2021
Q2 | $92.5M | Buy |
1,185,474
+82,103
| +7% | +$6.88M | 0.02% | 717 |
|
|
2021
Q1 | $90.4M | Buy |
1,103,371
+691,878
| +168% | +$56.7M | 0.02% | 636 |
|
|
2020
Q4 | $34M | Sell |
411,493
-442,440
| -52% | -$32.7M | 0.01% | 1278 |
|
|
2020
Q3 | $55.5M | Buy |
853,933
+660,151
| +341% | +$42.6M | 0.02% | 790 |
|
|
2020
Q2 | $12M | Sell |
193,782
-999,959
| -84% | -$67.8M | ﹤0.01% | 2019 |
|
|
2020
Q1 | $76.4M | Buy |
1,193,741
+565,697
| +90% | +$41M | 0.03% | 448 |
|
|
2019
Q4 | $43.5M | Sell |
628,044
-169,331
| -21% | -$11.6M | 0.02% | 859 |
|
|
2019
Q3 | $50.5M | Buy |
797,375
+62,655
| +9% | +$3.96M | 0.02% | 757 |
|
|
2019
Q2 | $46.6M | Buy |
734,720
+282,806
| +63% | +$17.3M | 0.02% | 767 |
|
|
2019
Q1 | $26.4M | Sell |
451,914
-31,501
| -7% | -$2.01M | 0.01% | 1108 |
|
|
2018
Q4 | $29.8M | Buy |
483,415
+403,317
| +504% | +$28.8M | 0.02% | 928 |
|
|
2018
Q3 | $6.24M | Buy |
80,098
+73,486
| +1,111% | +$5.62M | ﹤0.01% | 2703 |
|
|
2018
Q2 | $448K | Sell |
6,612
-704
| -10% | -$44.2K | ﹤0.01% | 6551 |
|
|
2018
Q1 | $418K | Sell |
7,316
-166,922
| -96% | -$8.99M | ﹤0.01% | 6206 |
|
|
2017
Q4 | $8.61M | Sell |
174,238
-72,180
| -29% | -$3.45M | 0.01% | 1880 |
|
|
2017
Q3 | $11.4M | Buy |
246,418
+86,370
| +54% | +$3.87M | 0.01% | 1489 |
|
|
2017
Q2 | $7.75M | Buy |
160,048
+70,174
| +78% | +$3.23M | 0.01% | 1677 |
|
|
2017
Q1 | $3.85M | Buy |
89,874
+53,138
| +145% | +$2.19M | ﹤0.01% | 2310 |
|
|
2016
Q4 | $1.52M | Buy |
36,736
+21,888
| +147% | +$893K | ﹤0.01% | 3294 |
|
|
2016
Q3 | $602K | Buy |
14,848
+6,053
| +69% | +$247K | ﹤0.01% | 4568 |
|
|
2016
Q2 | $341K | Buy |
8,795
+666
| +8% | +$26.2K | ﹤0.01% | 5185 |
|
|
2016
Q1 | $306K | Sell |
8,129
-19,003
| -70% | -$660K | ﹤0.01% | 5235 |
|
|
2015
Q4 | $945K | Buy |
27,132
+26,093
| +2,511% | +$933K | ﹤0.01% | 3769 |
|
|
2015
Q3 | $40K | Sell |
1,039
-55,624
| -98% | -$2.43M | ﹤0.01% | 7923 |
|
|
2015
Q2 | $2.61M | Buy |
56,663
+52,540
| +1,274% | +$2.35M | ﹤0.01% | 2818 |
|
|
2015
Q1 | $183K | Sell |
4,123
-73,394
| -95% | -$3.16M | ﹤0.01% | 6434 |
|
|
2014
Q4 | $2.98M | Sell |
77,517
-357,598
| -82% | -$14M | ﹤0.01% | 2547 |
|
|
2014
Q3 | $16.1M | Buy |
+435,115
| New | +$16.7M | 0.02% | 1053 |
|
|
2014
Q2 | – | Sell |
-47,460
| Closed | -$1.7M | – | 8204 |
|
|
2014
Q1 | $1.7M | Sell |
47,460
-882
| -2% | -$28.9K | ﹤0.01% | 2902 |
|
|
2013
Q4 | $1.61M | Buy |
+48,342
| New | +$1.69M | ﹤0.01% | 2757 |
|
|
2013
Q3 | – | Sell |
-2,956
| Closed | -$85K | – | 6762 |
|
|
2013
Q2 | $85K | Hold |
2,956
| – | – | ﹤0.01% | 5333 |
|
Other funds holding EHC
Ken Griffin's EHC Position: Q3 2026 in Review
Ken Griffin reduced its Encompass Health (EHC) stake by 0.33% in Q3 2026, selling an estimated $990K and leaving 2,554,703 shares worth $310M. The position accounts for 0.03% of the portfolio, ranked #394.
Ken Griffin first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. 630 funds tracked by Wall St. Rank hold EHC as of Q3 2026.
- Ken Griffin held 2,554,703 shares of Encompass Health worth $310M as of Q3 2026.
- Ken Griffin sold 8,401 Encompass Health shares in Q3 2026, an estimated $990K.
- Encompass Health made up 0.03% of Ken Griffin's portfolio in Q3 2026, its #394 holding.
- Ken Griffin first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
- 630 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.